Pages that link to "Q42695463"
Jump to navigation
Jump to search
The following pages link to Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1. (Q42695463):
Displaying 8 items.
- Mechanisms of Kv2.1 channel inhibition by celecoxib--modification of gating and channel block (Q33673130) (← links)
- Auranofin protects against anthrax lethal toxin-induced activation of the Nlrp1b inflammasome (Q33768371) (← links)
- Disease allele-dependent small-molecule sensitivities in blood cells from monogenic diabetes (Q34490707) (← links)
- Regulation of antiarrhythmic drug propafenone effects on the c-type Kv1.4 potassium channel by PHo and K+ (Q37116817) (← links)
- K+ channel modulators for the treatment of neurological disorders and autoimmune diseases (Q37162392) (← links)
- Effects of diltiazem and propafenone on the inactivation and recovery kinetics of fKv1.4 channel currents expressed in Xenopus oocytes (Q37727420) (← links)
- Overlapping binding sites of structurally different antiarrhythmics flecainide and propafenone in the subunit interface of potassium channel Kv2.1. (Q41833846) (← links)
- Molecular modeling of benzothiazepine binding in the L-type calcium channel (Q46656901) (← links)